Basic Sciences
-
Three from Vanderbilt community selected to participate in Endocrine Society’s leadership program
A Vanderbilt graduate student and two members of the Meharry-Vanderbilt Alliance joined the Endocrine Society’s leadership program, which provides scientists with leadership development, expanded skills in hands-on training, and networking opportunities with endocrinology leaders. Read MoreFeb. 21, 2024
-
Torres becomes first Vanderbilt graduate student to receive AAC&U’s Future Leaders Award
In addition to her laboratory research and academic successes, Ph.D. candidate Teresa Torres works to promote DEI at Vanderbilt, which has earned her the AAC&U’s K. Patricia Cross Future Leaders Award. She is the first Vanderbilt graduate student to receive this award. Read MoreJan. 19, 2024
-
Investigating the direct effects of SSNA1 on microtubules
By Emily Overway Marija Žanić, Ph.D. The lab of Marija Žanić, professor of cell and developmental biology, is investigating the regulation of microtubules. Work led by former postdoctoral fellow Elizabeth Lawrence, recently published in eLife, details the role of microtubule-associated protein SSNA1 in… Read MoreApr. 19, 2022
-
Pietenpol named AACR Fellow
The American Association for Cancer Research (AACR) has inducted Jennifer Pietenpol, PhD, and Yu Shyr, PhD, into the 2022 class of Fellows of the AACR Academy. The mission of the AACR Academy is to recognize and honor distinguished scientists whose scientific contributions have propelled significant innovation and progress against cancer. Read MoreMar. 24, 2022
-
Mass spectrometry analysis reveals massive insight into neuronal signaling
Heidi Hamm, Yun Young Yim By Emily Overway Researchers in the lab of Heidi Hamm, a professor of pharmacology who also holds the Aileen M. Lange and Annie Mary Lyle Chair in Cardiovascular Research, recently published a paper exploring the G protein subunits that interact with the SNARE complex. The… Read MoreMar. 3, 2022
-
CD40 expression correlates with response to immunotherapy in melanoma patients
L-R: Ann Richmond, Chi Yan By Wendy Bindeman Ann Richmond, professor of pharmacology, and Chi Yan, a research assistant professor in the Richmond lab, recently published a study showing that expression of a protein called CD40 can be used to predict response to immunotherapy in malignant melanoma. Read MoreMar. 1, 2022
-
Patel Lab earns new grant to study evolutionary trade-offs between reproduction and aging
Assistant Professor of Biological Sciences Maulik Patel and his lab have received a Pilot Research Grant from the Vanderbilt Evolutionary Studies Initiative to study reproduction and aging. According to one theory in evolution, aging is the price animals pay for reproduction. Research in the Patel lab uses the tiny but… Read MoreFeb. 4, 2022
-
Ege Kavalali to lead pharmacology department in School of Medicine Basic Sciences
Ege T. Kavalali, William Stokes Professor of Experimental Therapeutics, has been named chair of the Department of Pharmacology in Vanderbilt University School of Medicine Basic Sciences. National leaders in pharmacology, members of the pharmacology department at Vanderbilt and Lawrence J. Marnett, dean… Read MoreFeb. 4, 2022
-
VUMC study raises hope for improving treatment of kidney disease
Researchers at Vanderbilt University Medical Center have revealed an important mechanism in the kidney by which a cell surface receptor known as DDR1 fans the flames of inflammation and fibrosis that ultimately lead to kidney failure. Their findings, published recently in JCI Insight, a journal of the American Society for… Read MoreFeb. 3, 2022
-
Profiling chromatin accessibility and DNA methylation—simultaneously
Research led by Emily Hodges, assistant professor of biochemistry, first-author Lindsey Guerin, a graduate student in the Hodges lab, and Kelly Barnett, a recent graduate of the Hodges lab, developed and tested a new method called ATAC-Me, which profiles multiple epigenetic features, including DNA methylation, simultaneously from a single DNA… Read MoreFeb. 1, 2022